Phthalic Acid

Phthalic Acid

SCHEMBL1740439

O=C(O)c1ccccc1C(=O)O.[Zn]

nearest known ligand 0.93

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.93
ALOX15 P16050 1/20 0.93
AKR1C3 P42330 3/20 0.67
NAPRT Q6XQN6 2/20 0.65
KDM4E B2RXH2 1/20 0.65
CA12 O43570 1/20 0.65
CA1 P00915 1/20 0.65
CA2 P00918 1/20 0.65
HMGB1 P09429 1/20 0.65
HPGD P15428 1/20 0.65
CA4 P22748 1/20 0.65
CA6 P23280 1/20 0.65
CA7 P43166 1/20 0.65
SMN1; SMN2 Q16637 1/20 0.65
CA9 Q16790 1/20 0.65
CA14 Q9ULX7 1/20 0.65
MAPT P10636 2/20 0.62
HDAC8 Q9BY41 1/20 0.62
POLB P06746 1/20 0.59
NR4A1 P22736 3/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phthalic Acid SCHEMBL28168172 0.97 ALDH1A1 (0.88) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL8671920 0.97 ALDH1A1 (1.00) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL4452470 0.97 ALDH1A1 (1.00) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL29364035 0.97 ALDH1A1 (1.00) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL10477086 0.97 ALDH1A1 (1.00) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL1686043 0.97 ALDH1A1 (1.00) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL146125 0.97 ALDH1A1 (1.00) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL5668586 0.97 ALDH1A1 (1.00) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL1808 0.97 ALDH1A1 (1.00) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL1332278 0.97 ALDH1A1 (1.00) ALDH1A1ALOX15AKR1C3NAPRTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 324 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3601449-B1 SYNERGISTIC METAL POLYCARBOXYLATE CORROSION INHIBITORS US NAVY (US) 2025-09-17 EP claimed
CN-119753835-A Cubic zinc blende structure nanocrystalline and preparation method thereof 广东粤港澳大湾区国家纳米科技创新研究院 2025-04-04 CN claimed
CN-118978794-A Preparation method of chain-extended nucleation modified poly (butylene succinate) 华东理工大学 2024-11-19 CN claimed
CN-117986745-B LDHs-based synergistic flame-retardant cable insulation material and preparation process thereof 江苏馨德高分子材料股份有限公司 2024-07-30 CN claimed
CN-117986745-A LDHs-based synergistic flame-retardant cable insulation material and preparation process thereof 江苏馨德高分子材料股份有限公司 2024-05-07 CN claimed
CN-116376219-A Patch type control surface heat-proof material and forming process method thereof 北京新风航天装备有限公司 2023-07-04 CN claimed
CN-116230880-A Positive electrode material, preparation method thereof and lithium ion battery 贝特瑞(江苏)新材料科技有限公司 2023-06-06 CN claimed
CN-115926696-A Self-adhesive glue for self-adhesive waterproof coiled material and manufacturing method thereof 费米子(深圳)科技有限公司 2023-04-07 CN claimed
CN-115368655-A Special vulcanization system composition for chloroprene rubber and preparation method thereof 常州市五洲环保科技有限公司 2022-11-22 CN claimed
CN-115322482-A High-impact-resistance and high-fluidity homo-polypropylene material and preparation method thereof 北方华锦化学工业股份有限公司 2022-11-11 CN claimed
EP-2062904-B1 Compound salts of diorganyl phosphinic acids and carbolic acids CLARIANT FINANCE BVI LTD (VG) 2010-06-16 EP claimed
US-20090137707-A1 Mixed salts of diorganylphosphinic acids and carboxylic acids CLARIANT INTERNATIONAL LTD. 2009-05-28 US claimed
CN-101402726-A Combined catalyst of combined polymerization of carbonic anhydride and epoxide, and preparing method therefor CHANGCHUN APPLIED CHEMISTRY (CN) 2009-04-08 CN claimed
EP-1212277-B1 AN INTEGRATED PROCESS FOR THE PRODUCTION OF 2,6-NAPHTHALENE DICARBOXYLIC ACID MOSSI & GHISOLFI INT SA (LU) 2004-04-21 EP claimed
US-6448436-B1 RELATIVELY IMPURE METHYLNAPHTHALENE REACTANT; DEBROMINATION OF THE OXIDATION PRODUCT IN THE LIQUID PHASE, AND AVOIDS THE ISOLATION OF PURIFIED NAPHTHOIC ACID MOSSI & GHISOLFI OVERSEAS, S. A. (LU) 2002-09-10 US claimed
EP-1212277-A2 AN INTEGRATED PROCESS FOR THE PRODUCTION OF 2,6-NAPHTHALENE DICARBOXYLIC ACID Mossi & Ghisolfi Overseas S.A. (LU) 2002-06-12 EP claimed
EP-0790621-B1 A method of preventing the deposition of radioactive corrosion products in nuclear plants WESTINGHOUSE ATOM AB (SE) 2001-08-22 EP claimed
WO-2001016074-A2 AN INTEGRATED PROCESS FOR THE PRODUCTION OF 2,6-NAPHTHALENE DICARBOXYLIC ACID MOSSI & GHISOLFI OVERSEAS S.A. (LU) 2001-03-08 WO claimed
EP-0790621-A1 A method of preventing the deposition of radioactive corrosion products in nuclear plants ABB ATOM AB (SE) 1997-08-20 EP claimed
US-3996142-A Smoke and fire retardants for halogen-containing plastic compositions comprising the reaction product of magnesium oxide and a zinc salt of an acid NL INDUSTRIES, INC. (US) 1976-12-07 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137707-A1 Mixed salts of diorganylphosphinic acids and carboxylic acids SLC10A6, SLC9A5, SLC9A3 ALDH1A1 1907/4885ALOX15 673/4885AKR1C3 475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.